Abstract:Active form of vitamin D (VitD) enhances human innate immunity against Mycobacterium tuberculosis (Mtb) infection. Our previous studies showed that MIR337-3p was highly expressed in lymphocytes of tuberculosis (TB) patients. Here, we identified the mechanism of MIR337-3p in the regulation of fast-acting anti-TB immunity by inhibiting VitD-dependent antimicrobial response pathways. While high-level MIR337-3p expression was induced by mycobacterial infection in cellular models and mice, TB patients exhibited significantly increased MIR337-3p in CD14+ monocytes/macrophages, innate-like Vγ2+ T cells, and CD8+ lymphocytes containing natural killer (NK)/innate lymphoid cells. MIR337-3p promoted the mycobacterial entry/infection and replication/growth in host target cells: macrophages and lung epithelial cells. Such MIR337-3p-enhanced pathogenicity coincided with the MIR337-3p depression of VitD-dependent antimicrobial response of cytochrome P450, family 27, subfamily b, polypeptide 1 (CYP27B1)/Beta-defensin 4 (DEFB4A)/ cathelicidin antimicrobial peptide CAMP pathways. Surprisingly, single MIR337-3p species could specifically target both the Toll-like receptor 4 (TLR4) and signal transducer and activator of transcription 3 (STAT3) 3'-untranslated regions (UTRs) to depress the TLR4/MYD88 and STAT3 signals and impair either of the two signals inhibiting the VitD-dependent antimicrobial pathways in macrophages. Concurrently, human peripheral blood mononuclear cells (PBMCs) expressing high-level MIR337-3p exhibited a reduced ability of innate cell populations to mount fast-acting cellular immunity against intracellular mycobacterial infection. Furthermore, a higher expression of Mir337-3p after mycobacterial infection of mice coincided with much greater colony-forming unit (CFU) counts in lungs and even the death of infected animals, whereas Mir337-3p inhibitor treatment of infected mice reduced Mir337-3p levels and reversed Mir337-3p-mediated increases in CFU counts. Thus, TB-driven single MIR337-3p species could specifically target/impair both TLR4/MYD88 and STAT3 activation signals, inhibiting VitD-dependent antimicrobial response and fast-acting anti-TB immunity, leading to enhanced pathogenicity.

Inhibition of IFN-γ-Induced Nitric Oxide Dependent Antimycobacterial Activity by Mir-155 and C/EBPβ

Mycobacterium Marinum Down-Regulates Mir-148A in Macrophages in an EsxA-dependent Manner.

Microrna-146A Promotes Mycobacterial Survival in Macrophages Through Suppressing Nitric Oxide Production.

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]

MicroRNA-146a Represses Mycobacteria-Induced Inflammatory Response and Facilitates Bacterial Replication Via Targeting IRAK-1 and TRAF-6

MicroRNA-155 Induction by Mycobacterium Bovis BCG Enhances ROS Production Through Targeting SHIP1

MIR337-3p Enhances Mycobacterial Pathogenicity Involving TLR4/MYD88 and STAT3 Signals, Impairing VDR Antimicrobial Response and Fast-Acting Immunity

Novel Mir-1958 Promotes Mycobacterium Tuberculosis Survival in RAW264.7 Cells by Inhibiting Autophagy Via Atg5

Inductive Microrna‐21 Impairs Anti‐mycobacterial Responses by Targeting IL‐12 and Bcl‐2

Macrophage-mediated Inflammatory Response Decreases Mycobacterial Survival in Mouse MSCs by Augmenting NO Production

Microrna-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb

miRNAs in immune responses to Mycobacterium tuberculosis infection.

MiR-25 blunts autophagy and promotes the survival of Mycobacterium tuberculosis by regulating NPC1

Enhancement of mycobacterial pathogenesis by host interferon-γ

MiR-140 modulates the inflammatory responses of Mycobacterium tuberculosis-infected macrophages by targeting TRAF6.

MicroRNA-144-3p Inhibits Host Lipid Catabolism and Autophagy by Targeting PPARα and ABCA1 During Mycobacterium Tuberculosis Infection

Sirtuin 7 Regulates Nitric Oxide Production and Apoptosis to Promote Mycobacterial Clearance in Macrophages

Mir-146a Negatively Regulates Dectin-1-Induced Inflammatory Responses

Modulating ferroptosis and mycobactericidal activity in lung epithelial cells via YY1/iNOS pathway

Mir-155 and Its Star-Form Partner Mir-155* Cooperatively Regulate Type I Interferon Production by Human Plasmacytoid Dendritic Cells.

Mmu-let-7a-5p inhibits macrophage apoptosis by targeting CASP3 to increase bacterial load and facilities mycobacterium survival